Med. praxi. 2011;8(2):83-85

Deep vein trombosis in young women (notes for practitioners)

MUDr.Hana Brůhová
Angiologie, I. interní klinika FN v Plzni

The young women with deep vein thrombosis (DVT) make a special group which needs a careful examination of risk and releasing factors,

especially due to possible relationship with pregnancy and contraceptives and with congenital or acquired thrombophilias as well. The

results of this examination are important not only for therapy and recurrence of DVT in the patient but they can be potentially beneficial

for the relatives, too. The multidisciplinary cooperation is very important.

Keywords: deep vein thrombosis, young women, thrombophilias

Published: February 22, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brůhová H. Deep vein trombosis in young women (notes for practitioners). Med. praxi. 2011;8(2):83-85.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Heit JA, Silverstein MD, Mohr DN, et al. The Epidemiology of Venous Thromboembolism in the Community. Thromb Haemost 2001; 86: 452-463. Go to original source... Go to PubMed...
    2. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism. A 25-Year Population-Based Study. Arch Intern Med 1998; 158: 585-593. Go to original source... Go to PubMed...
    3. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125(1): 1-7. Go to original source... Go to PubMed...
    4. Kahn SR, Ginsberg JS. Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome. Arch Intern Med 2004; 164: 17-26. Go to original source... Go to PubMed...
    5. Schulman S, Lindmarker P, Holmström M, et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. Thromb Haemost 2006; 4: 734-742. Go to original source... Go to PubMed...
    6. Gaillyová R, Čech Z, Vilémová M, et al. Vrozené trombofilie a cytogenetické nálezy u pacientů s opakovanými fetálními ztrátami. Prakt Gyn 2005; 9(3): 9-12.
    7. Rasmussen A, Ravn P. High frequency of congenital thrombophilia in women with pathological pregnancies. Acta Obstet Gynecol Scand 2004; 83(9): 808-817. Go to original source... Go to PubMed...
    8. Nutescu EA, Michaud JB, Caprini JA. Evaluation of hypercoagulable states and molecular markers of acute venous thrombosis. In: Gloviczki P, et al. Handbook of venous disorders, 3rd ed., Guidelines of the American Venous Forum. London: Hodder Arnold, 2009: 113-128.
    9. Kvasnička J. Dědičné trombofilie - doporučení k provádění genetických testů v klinické praxi. Čas Lék čes 2010; 149: 468-471.
    10. Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-762. Go to original source... Go to PubMed...
    11. Meissner MH. The epidemiology of and risk factors for acute deep venous thrombosis. In: Gloviczki P, et al. Handbook of venous disorders, 3rd ed., Guidelines of the American Venous Forum. London: Hodder Arnold, 2009: 94-104.
    12. Lindhof-Last E, Luxemburg B. Evidence-based indications for thrombophilia screening. VASA 2008; 37: 19-30. Go to original source... Go to PubMed...
    13. Legnani C, Palareti G, Guazzaloca G, et al. Venous thromboembolism in young women. Eur Heart J 2002; 23(12): 984-990. Go to original source... Go to PubMed...
    14. Vanderbroucke JP, Koster T, Briët E, et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factors V Leiden mutation. Lancet 1994; 344: 1453-1457. Go to original source... Go to PubMed...
    15. Procházka M, Procházková J. Hormonální antikoncepce a trombofilní stavy. Interní Med 2010; 12(7, 8): 369-371.
    16. Králová S, Klodová D, Gumulec J, et al. Heparinem indukovaná trombocytopenie. Vnitř Lék 2006; 52(S1): 98-106. Go to PubMed...
    17. Goldhaber SZ. Optimal Duration of Anticoagulation After Venous Thromboembolism: Fixed and Evidence-Based, or Flexible and Personalized? Ann Intern Med 2009; 150(9): 644-646. Go to original source... Go to PubMed...
    18. Levine MN, Hirsch J, Gent M, et al. Optimal duration of oral anticoagulation therapy: a randomized trial comparing four weeks with three month of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74: 606-611. Go to original source... Go to PubMed...
    19. Kearon C, Kahn S, Agnelli G, et al. Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008; 133: 454-545. Go to original source...
    20. Geerts WH, Bergqvist D, Pineo G, et al. Prevention of Venous Thromboembolism: American College of Chest Physicians, Evidence-Based Clinical Practice Guidelines (8th edition). Ches 2008; 133: 381-453. Go to original source...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.